Oxaliplatin-safety profile: Neurotoxicity

被引：230

作者：

Grothey, A

机构：

[1] Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA

[2] Univ Halle Wittenberg, Dept Hematol Oncol, Halle An Der Saale, Germany

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 04期

关键词：

D O I：

10.1016/S0093-7754(03)00399-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5 / 13

页数：9

共 41 条

[11] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[12]

DEGRAMONT A, 2002, P AN M AM SOC CLIN, V21, pA132

[13] Prevention of oxaliplatin-induced neuropathy by carbamazepine: A pilot study [J].

Eckel, F ;

Schmelz, R ;

Adelsberger, H ;

Erdmann, J ;

Quasthoff, S ;

Lersch, C .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (03) :78-82

[14]

Extra JM, 1998, SEMIN ONCOL, V25, P13

[15] Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures [J].

Gamelin, E ;

Gamelin, L ;

Bossi, L ;

Quasthoff, S .

SEMINARS IN ONCOLOGY, 2002, 29 (05) :21-33

[16]

GAMELIN E, 2002, P AN M AM SOC CLIN, V21, pA157

[17]

Gamelin Laurence, 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P935

[18]

GARUFI C, 1999, P AN M AM SOC CLIN, V18, pA244

[19] Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid [J].

Gedlicka, C ;

Scheithauer, W ;

Schüll, B ;

Kornek, GV .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3359-3361

[20]

GOLDBERG RM, 2000, P AN M AM SOC CLIN, V21, pA128

← 1 2 3 4 5 →